119 related articles for article (PubMed ID: 16373593)
1. Effect of phosphodiesterase 5 inhibitor on alteration in vascular smooth muscle sensitivity and renal function in rats with liver cirrhosis.
Tahseldar-Roumieh R; Ghali-Ghoul R; Lugnier C; Sabra R
Am J Physiol Heart Circ Physiol; 2006 Jan; 290(1):H481-8. PubMed ID: 16373593
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular effects of a novel, potent and selective phosphodiesterase 5 inhibitor, DMPPO: in vitro and in vivo characterization.
Delpy E; le Monnier de Gouville AC
Br J Pharmacol; 1996 Jul; 118(6):1377-84. PubMed ID: 8832060
[TBL] [Abstract][Full Text] [Related]
3. Increased cGMP phosphodiesterase activity mediates renal resistance to ANP in rats with bile duct ligation.
Ni XP; Safai M; Gardner DG; Humphreys MH
Kidney Int; 2001 Apr; 59(4):1264-73. PubMed ID: 11260387
[TBL] [Abstract][Full Text] [Related]
4. Temporal changes in vascular reactivity in early diabetes mellitus in rats: role of changes in endothelial factors and in phosphodiesterase activity.
Abboud K; Bassila JC; Ghali-Ghoul R; Sabra R
Am J Physiol Heart Circ Physiol; 2009 Aug; 297(2):H836-45. PubMed ID: 19542492
[TBL] [Abstract][Full Text] [Related]
5. Effects of cyclic GMP elevation on isoprenaline-induced increase in cyclic AMP and relaxation in rat aortic smooth muscle: role of phosphodiesterase 3.
Delpy E; Coste H; Gouville AC
Br J Pharmacol; 1996 Oct; 119(3):471-8. PubMed ID: 8894166
[TBL] [Abstract][Full Text] [Related]
6. PDEs1-5 activity and expression in tissues of cirrhotic rats reveal a role for aortic PDE3 in NO desensitization.
Tahseldar-Roumieh R; Keravis T; Maarouf S; Justiniano H; Sabra R; Lugnier C
Int J Exp Pathol; 2009 Dec; 90(6):605-14. PubMed ID: 19758418
[TBL] [Abstract][Full Text] [Related]
7. Vitamin E supplementation reverses renal altered vascular reactivity in chronic bile duct-ligated rats.
Alcaraz A; Iyú D; Atucha NM; García-Estañ J; Ortiz MC
Am J Physiol Regul Integr Comp Physiol; 2007 Apr; 292(4):R1486-93. PubMed ID: 17158269
[TBL] [Abstract][Full Text] [Related]
8. Characterization of a novel potent and specific inhibitor of type V phosphodiesterase.
Coste H; Grondin P
Biochem Pharmacol; 1995 Nov; 50(10):1577-85. PubMed ID: 7503759
[TBL] [Abstract][Full Text] [Related]
9. Effect of DMPPO, a phosphodiesterase type 5 inhibitor, on hypoxic pulmonary hypertension in rats.
Eddahibi S; Raffestin B; Le Monnier de Gouville AC; Adnot S
Br J Pharmacol; 1998 Oct; 125(4):681-8. PubMed ID: 9831902
[TBL] [Abstract][Full Text] [Related]
10. Effect of chronic administration of sildenafil on sodium retention and on the hemodynamic complications associated with liver cirrhosis in the rat.
Ghali-Ghoul R; Tahseldar-Roumieh R; Sabra R
Eur J Pharmacol; 2007 Oct; 572(1):49-56. PubMed ID: 17610866
[TBL] [Abstract][Full Text] [Related]
11. Cyclic GMP potentiation by WIN 58237, a novel cyclic nucleotide phosphodiesterase inhibitor.
Silver PJ; Dundore RL; Bode DC; de Garavilla L; Buchholz RA; van Aller G; Hamel LT; Bacon E; Singh B; Lesher GY
J Pharmacol Exp Ther; 1994 Dec; 271(3):1143-9. PubMed ID: 7996419
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of phosphodiesterase 5 selectively reverses nitrate tolerance in the venous circulation.
MacPherson JD; Gillespie TD; Dunkerley HA; Maurice DH; Bennett BM
J Pharmacol Exp Ther; 2006 Apr; 317(1):188-95. PubMed ID: 16330494
[TBL] [Abstract][Full Text] [Related]
13. Relaxation effect of nitric oxide-donor on diabetic penile smooth muscle in vitro.
Taher A; Birowo P; Kamil ST; Shahab N
Clin Hemorheol Microcirc; 2000; 23(2-4):277-81. PubMed ID: 11321451
[TBL] [Abstract][Full Text] [Related]
14. Rat renal function four days after bile-duct ligation: effects of indomethacin and vasoactive agents.
Monasterolo LA; Ochoa JE; Elías MM
Ren Fail; 2002 Mar; 24(2):111-26. PubMed ID: 12071586
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of phosphodiesterase 1A1 expression is associated with the development of nitrate tolerance.
Kim D; Rybalkin SD; Pi X; Wang Y; Zhang C; Munzel T; Beavo JA; Berk BC; Yan C
Circulation; 2001 Nov; 104(19):2338-43. PubMed ID: 11696475
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo interactions of nitrovasodilators and zaprinast, a cGMP-selective phosphodiesterase inhibitor.
Merkel LA; Rivera LM; Perrone MH; Lappe RW
Eur J Pharmacol; 1992 May; 216(1):29-35. PubMed ID: 1326438
[TBL] [Abstract][Full Text] [Related]
17. Prevention of nitroglycerin tolerance in vitro by T0156, a selective phosphodiesterase type 5 inhibitor.
Liu CQ; Leung FP; Lee VW; Lau CW; Yao X; Lu L; Huang Y
Eur J Pharmacol; 2008 Aug; 590(1-3):250-4. PubMed ID: 18554583
[TBL] [Abstract][Full Text] [Related]
18. Increased vascular heme oxygenase-1 expression contributes to arterial vasodilation in experimental cirrhosis in rats.
Chen YC; Ginès P; Yang J; Summer SN; Falk S; Russell NS; Schrier RW
Hepatology; 2004 Apr; 39(4):1075-87. PubMed ID: 15057912
[TBL] [Abstract][Full Text] [Related]
19. Endothelium-dependent relaxation of rat aorta by butein, a novel cyclic AMP-specific phosphodiesterase inhibitor.
Yu SM; Cheng ZJ; Kuo SC
Eur J Pharmacol; 1995 Jun; 280(1):69-77. PubMed ID: 7498256
[TBL] [Abstract][Full Text] [Related]
20. Mesenteric artery responsiveness to acetylcholine and phenylephrine in cirrhotic rats challenged with endotoxin: the role of TLR4.
Ostadhadi S; Rezayat SM; Ejtemaei-Mehr S; Tavangar SM; Nikoui V; Jazaeri F; Eftekhari G; Abdollahi A; Dehpour AR
Can J Physiol Pharmacol; 2015 Jun; 93(6):475-83. PubMed ID: 25978623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
